Racial and Ethnic Disparities in Breast Cancer Survival: Emergence of a Clinically Distinct Hispanic Black Population.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
17
6
2021
medline:
24
9
2021
entrez:
16
6
2021
Statut:
ppublish
Résumé
To understand the impact of Black race on breast cancer (BC) presentation, treatment, and survival among Hispanics. It is well-documented that non-Hispanic Blacks (NHB) present with late-stage disease, are less likely to complete treatment, and have worse survival compared to their non-Hispanic White (NHW) counterparts. However, no data evaluates whether this disparity extends to Hispanic Blacks (HB) and Hispanic Whites (HW). Given our location in Miami, gateway to Latin America and the Caribbean, we have the diversity to evaluate BC outcomes in HB and HW. Retrospective cohort study of stage I-IV BC patients treated at our institution from 2005-2017. Kaplan-Meier survival curves were generated and compared using the log-rank test. Multivariable survival models were computed using Cox proportional hazards regression. Race/ethnicity distribution of 5951 patients: 28% NHW, 51% HW, 3% HB, and 18% NHB. HB were more economically disadvantaged, had more aggressive disease, and less treatment compliant compared to HW. 5-year OS by race/ethnicity was: 85% NHW, 84.8% HW, 79.4% HB, and 72.7% NHB (P < 0.001). After adjusting for covariates, NHB was an independent predictor of worse OS [hazard ratio:1.25 (95% confidence interval: 1.01-1.52), P < 0.041)]. In this first comprehensive analysis of HB and HW, HB have worse OS compared to HW, suggesting that race/ethnicity is a complex variable acting as a proxy for tumor and host biology, as well as individual and neighborhood-level factors impacted by structural racism. This study identifies markers of vulnerability associated with Black race and markers of resiliency associated with Hispanic ethnicity to narrow a persistent BC survival gap.
Sections du résumé
OBJECTIVE
To understand the impact of Black race on breast cancer (BC) presentation, treatment, and survival among Hispanics.
SUMMARY OF BACKGROUND DATA
It is well-documented that non-Hispanic Blacks (NHB) present with late-stage disease, are less likely to complete treatment, and have worse survival compared to their non-Hispanic White (NHW) counterparts. However, no data evaluates whether this disparity extends to Hispanic Blacks (HB) and Hispanic Whites (HW). Given our location in Miami, gateway to Latin America and the Caribbean, we have the diversity to evaluate BC outcomes in HB and HW.
METHODS
Retrospective cohort study of stage I-IV BC patients treated at our institution from 2005-2017. Kaplan-Meier survival curves were generated and compared using the log-rank test. Multivariable survival models were computed using Cox proportional hazards regression.
RESULTS
Race/ethnicity distribution of 5951 patients: 28% NHW, 51% HW, 3% HB, and 18% NHB. HB were more economically disadvantaged, had more aggressive disease, and less treatment compliant compared to HW. 5-year OS by race/ethnicity was: 85% NHW, 84.8% HW, 79.4% HB, and 72.7% NHB (P < 0.001). After adjusting for covariates, NHB was an independent predictor of worse OS [hazard ratio:1.25 (95% confidence interval: 1.01-1.52), P < 0.041)].
CONCLUSIONS
In this first comprehensive analysis of HB and HW, HB have worse OS compared to HW, suggesting that race/ethnicity is a complex variable acting as a proxy for tumor and host biology, as well as individual and neighborhood-level factors impacted by structural racism. This study identifies markers of vulnerability associated with Black race and markers of resiliency associated with Hispanic ethnicity to narrow a persistent BC survival gap.
Identifiants
pubmed: 34132699
doi: 10.1097/SLA.0000000000005004
pii: 00000658-202109000-00027
pmc: PMC8384141
mid: NIHMS1714645
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e269-e275Subventions
Organisme : NCI NIH HHS
ID : K12 CA226330
Pays : United States
Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Parker, K., Morin, R., Menasce Horowitz, J. (2019, December 31). Views of America's future in 2050. Retrieved September 10, 2020, Available at: https://www.pewsocialtrends.org/2019/03/21/america-in-2050/
Keegan TH, Quach T, Shema S, et al. The influence of nativity and neighborhoods on breast cancer stage at diagnosis and survival among California Hispanic women. BMC Cancer 2010; 10:603.
Pinheiro PS, Callahan KE, Koru-Sengul T, et al. Risk of cancer death among White, Black, and Hispanic populations in South Florida. Prev Chronic Dis 2019; 16:16.
Stern MC, Fejerman L, Das R, et al. Variability in cancer risk and outcomes within US Latinos by National Origin and Genetic Ancestry. Curr Epidemiol Rep 2016; 3:181–190.
Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 2011; 127:729–738.
Iqbal J, Ginsburg O, Rochon PA, et al. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 2015; 313:165–173.
Pinheiro PS, Williams M, Miller EA, et al. Cancer survival among Latinos and the Hispanic paradox. Cancer Causes Control 2011; 22:553–561.
Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163:49–56.
U.S. Census Bureau (2018). American Community Survey 1-year estimates. Retrieved from Census Reporter Profile page for Miami-Dade County, FL Available at: http://censusreporter.org/profiles/05000US12086-miami-dade-county-fl/
Noe-Bustamante, L. (2020, May 31). Key facts about U.S. Hispanics and their diverse heritage. Retrieved July 26, 2020, Available at: https://www.pewresearch.org/fact-tank/2019/09/16/key-facts-about-u-s-hispanics/
Allen VC Jr, Lachance C, Rios-Ellis B, et al. Issues in the Assessment of “Race” among Latinos: Implications for Research and Policy. Hisp J Behav Sci 2011; 33:411–424.
Scott LC, Mobley LR, Kuo T-M, et al. Update on triple-negative breast cancer disparities for the United States: a population-based study from the United States Cancer Statistics database, 2010 through 2014. Cancer 2019; 125:3412–3417.
Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg 2017; 152:485–493.
Newman LA, Reis-Filho JS, Morrow M, et al. The 2014 society of surgical oncology Susan G. Komen for the cure symposium: triple-negative breast cancer. Ann Surg Oncol 2015; 22:874–882.
Dietze E, Sistrunk C, Miranda-Carboni G, et al. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer 2015; 15:248–254.
Huo D, Hu H, Rhie SK, et al. Comparison of breast cancer molecular features and survival by African and European ancestry in the Cancer Genome Atlas. JAMA Oncol 2017; 3:1654–1662.
Conroy SM, Shariff-Marco S, Koo J, et al. Racial/ethnic differences in the impact of neighborhood social and built environment on breast cancer risk: the neighborhoods and breast cancer study. Cancer Epidemiol Biomarkers Prev 2017; 26:541–552.
Bailey ZD, Krieger N, Agénor M, et al. Structural racism and health inequities in the USA: evidence and interventions. Lancet 2017; 389:1453–1463.
Williams DR, Lawrence JA, Davis BA. Racism and health: evidence and needed research. Annu Rev Public Health 2019; 40:105–125.
Williams DR, Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep 2001; 116:404–416.
Noonan AS, Velasco-Mondragon HE, Wagner FA. Improving the health of African Americans in the USA: an overdue opportunity for social justice. Public health reviews 2016; 37:12.
Klassen AC, Smith KC, Shariff-Marco S, et al. A healthy mistrust: how worldview relates to attitudes about breast cancer screening in a cross-sectional survey of low-income women. Int J Equity Health 2008; 7:5.
Kennedy BR, Mathis CC, Woods AK. African Americans and their distrust of the health care system: healthcare for diverse populations. J Cult Divers 2007; 14:56–60.
Torres Á, Oliver J, Frecha C, et al. Cancer genomic resources and present needs in the Latin American region. Public Health Genomics 2017; 20:194–201.
Spratt DE, Chan T, Waldron L, et al. Racial/ethnic disparities in genomic sequencing. JAMA Oncol 2016; 2:1070–1074.
Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature 2016; 538:161–164.
Yuan J, Hu Z, Mahal BA, et al. Integrated analysis of genetic ancestry and genomic alterations across cancers. Cancer Cell 2018; 34:549–560.e9.
Fejerman L, John EM, Huntsman S, et al. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res 2008; 68:9723–9728.
Fejerman L, Romieu I, John EM, et al. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomark Prev 2010; 19:1074–1082.
Fejerman L, Hu D, Huntsman S, et al. Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer. Cancer Res 2013; 73:7243–7253.
Engmann NJ, Ergas IJ, Yao S, et al. Genetic ancestry is not associated with breast cancer recurrence or survival in U.S. Latina women enrolled in the Kaiser Permanente Pathways study. Cancer Epidemiol Biomark Prev 2017; 26:1466–1469.
Pinheiro PS, Bungum TJ. Country of origin and breast cancer survival. Asia Pac J Clin Oncol 2014; 10:279.
US Census Bureau. Population: Hispanic origin. Census.gov. Available at: https://www.census.gov/topics/population/hispanic-origin/about.html . Accessed January 17, 2021.
Pinheiro PS, Callahan KE, Boscoe FP, et al. Cancer-site-specific disparities in New York, including the 1945-1965 birth cohort's impact on liver cancer patterns. Cancer Epidemiol Biomarkers Prev 2018; 27:917–927.
Palloni A, Arias E. Paradox lost: explaining the Hispanic adult mortality advantage. Demography 2004; 41:385–415.
Cresce AR, Ramirez RR. Analysis of general Hispanic responses in census 2000. Population Division Working Paper 2003; https://www.census.gov/library/working-papers/2003/demo/POP-twps0072.html
Pinheiro PS, Bungum TJ, Jin H. Limitations in the imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results program. Cancer 2014; 120:3261–3262.
Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006; 13:279–292.
Turra CM, Elo IT. The impact of Salmon bias on the Hispanic mortality advantage: new evidence from social security data. Popul Res Policy Rev 2008; 27:515–530.
Kelly KN, Hernandez A, Yadegarynia S, et al. Overcoming disparities: multidisciplinary breast cancer care at a public safety net hospital. Breast Cancer Res Treat 2021; 187:197–206.